---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-169367"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2022-06-07T23:59:59+00:00"
generated_at: "2026-06-25T03:58:32.858479+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte annual meeting: directors re-elected, say-on-pay approved, auditor ratified

## Summary
- Peter Hirth re-elected as Class II director with 44,840,461 votes for, 2,557,604 withheld.
- Heath Lukatch re-elected as Class II director with 44,945,210 votes for, 2,452,855 withheld.
- Say-on-pay proposal passed with 47,263,430 for, 132,867 against, 1,768 abstentions.
- Future say-on-pay frequency set at one year based on 47,358,585 votes for one year.
- Deloitte & Touche LLP ratified as auditor for FY2022 with 51,800,260 for, 335 against.

## SEC filing metadata
- accession: 0001193125-22-169367
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2022-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000119312522169367/0001193125-22-169367-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000119312522169367/d318726d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-169367
- JSON: https://secwatch.observer/filing/0001193125-22-169367.json
- Plain text: https://secwatch.observer/filing/0001193125-22-169367.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.